Jeffrey Robert Ajer, EVP, Chief Commercial Officer at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 5,000 shares at $90.00 ($450K) on 2023-08-16, disclosed to the SEC on 2023-08-17.
Scheduled sale ($450k) by EVP, Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| NKTR | SELL | 2023-09-20 | $3K | — | Filing → |
| BMRN | SELL | 2023-01-27 | $11.3M | — | Filing → |
| BMRN | SELL | 2022-11-04 | $258K | — | Filing → |